DXCM DEXCOM INC.

UnitedHealthcare and Dexcom Bring Wearable Technology Solution, One-on-One Coaching to People Battling Type 2 Diabetes

UnitedHealthcare, the market leader in Medicare benefit plans1, and DexCom, Inc., the leader in continuous glucose monitoring for diabetes management, today announced an individualized glucose management pilot program driven by wearable technology to help people with Type 2 diabetes manage their condition in real time.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180110005422/en/

The program is being showcased this week at the International Consumer Electronics Show (CES), the annual technology convention in Las Vegas.

Eligible UnitedHealthcare Medicare Advantage plan participants can use the Dexcom Mobile Continuous Glucose Monitoring (CGM) System to track their blood glucose levels 24/7, enabling them to understand how their behaviors affect their glucose so they can take appropriate actions.

Participants also receive personalized diabetes coaching and an activity tracker to help them understand and act upon the data gathered by the CGM device. Together, these tools empower people with Type 2 diabetes to manage glucose levels and can result in increased glucose control, reductions in medications and improved confidence in managing their diabetes.

The program is part of UnitedHealthcare’s focus on integrating human support with data from real-time sources, such as digital health technology, and historical sources, like claims data, to help improve and personalize how people navigate the health care system.

“With more than 27 million people nationwide living with Type 2 diabetes2 there is urgent need to address this epidemic in new ways,” said Brian Thompson, CEO of UnitedHealthcare Medicare & Retirement. “Continuous glucose monitoring can be a game changer for people enrolled in our Medicare Advantage plans, as the data can be translated into personalized information that can be acted upon in real time.”

Dexcom’s technology consists of a sensor – usually worn on the abdomen – that reads glucose levels just beneath the skin. A transmitter sends the data to a smartphone, which processes and displays updated data every five minutes, and can reveal relationships between eating, exercise and blood sugar that are difficult to observe with only test strips and a glucose meter.

“Dexcom is thrilled to work with UnitedHealthcare to bring this program to people living with diabetes,” said Steve Pacelli, Dexcom’s executive vice president of strategy and corporate development. “The insights that CGM and this program provide can drive significant value to both patients and care providers in helping to better manage diabetes.”

UnitedHealthcare serves more than 4.3 million people in Medicare Advantage plans, 4.9 million people through its portfolio of Part D prescription drug plans, and 4.4 million beneficiaries through its Medicare supplement plans.

Nationwide, UnitedHealthcare serves one in five Medicare beneficiaries3.

UnitedHealthcare at CES 2018

UnitedHealthcare will demonstrate new technologies designed to help simplify the consumer health care experience by making information more accessible through personal technology devices including computers, smartphones and wearables.

UnitedHealthcare’s 3,500-square-foot booth is located in the Sands Convention Center, adjacent to the Digital Health Stage (Hall A – 43731). Numerous digital innovations will be demonstrated, including UnitedHealthcare Motion®, the UnitedHealthcare Healthy Pregnancy™ mobile app, Virtual Visits and health and well-being solution Rally®.

Conference attendees will also participate in a fundraiser for the Boys & Girls Clubs of Southern Nevada. For each mile cycled on the in-booth stationary bikes, UnitedHealthcare will donate $1 to the Club, up to $25,000. The donation will be delivered to the Club, along with 150 bike helmets, Monday, Jan. 15.

At CES 2018, executives from UnitedHealthcare, Optum and Rally Health will speak, including:

  • Paul Sterling, vice president of emerging products at UnitedHealthcare, will participate in a panel hosted by CNET.com about empowering patients with connected technology on Tuesday, Jan. 9, at 3 p.m. at the Las Vegas Convention Center (North Hall).
  • Dr. Richard Migliori will participate in a panel – “The Vicious Spiral: How Will the Opioid Crisis End?” – Wednesday, Jan. 10, at 10:45 a.m. at the Venetian, Level 4, Lando 4304.
  • Pat Keran, vice president of innovation and research & development at Optum (a UnitedHealth Group company), will participate in a panel – “Predictive Analytics: The New Clairvoyant Caregiver” – Wednesday, Jan. 10, at 2:15 p.m. at the Venetian, Level 4, Lando 4304.
  • Mike Jacobs, senior distinguished engineer at Optum, will participate in a fireside chat – “Healthcare Has Problems: Blockchain Has Answers” – Thursday, Jan. 11, at 10 a.m. at the Venetian, Level 4, Lando 4304.
  • Rebecca Madsen, UnitedHealthcare chief consumer officer, will participate in a fireside chat – “UnitedHealthcare Rallies Data into Action” – Thursday, Jan. 11, at 10:35 a.m. at the Venetian, Level 4, Lando 4304. She will be joined by Shawn Mobley, Rally Health Inc. chief revenue officer.
  • Kirsti Lay, a professional cyclist for Rally Cycling and former Olympian, and Sara Bergen, a Rally Cycling team rider and two-time World Championship participant, will participate in Q&A sessions on Thursday, Jan. 11, and Friday, Jan. 12, at 1 p.m. The cyclists will discuss the connection between technology and athletic training and performance.

Visit www.uhc.com/ces or follow @UHC on Twitter, and through the #DigitalHealthCES hashtag.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, CA, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) products and tools for adult and pediatric patients. With exceptional performance, patient comfort and lifestyle flexibility at the heart of its technology, users have consistently ranked DexCom highest in customer satisfaction and loyalty. For more information on the DexCom CGM, visit www.dexcom.com.

About UnitedHealthcare

UnitedHealthcare is dedicated to helping people nationwide live healthier lives by simplifying the health care experience, meeting consumer health and wellness needs, and sustaining trusted relationships with care providers. The company offers the full spectrum of health benefit programs for individuals, employers, military service members, retirees and their families, and Medicare and Medicaid beneficiaries, and contracts directly with 1 million physicians and care professionals, and 6,000 hospitals and other care facilities nationwide. UnitedHealthcare is one of the businesses of UnitedHealth Group (NYSE: UNH), a diversified Fortune 50 health and well-being company. For more information, visit UnitedHealthcare at www.uhc.com or follow @UHC on Twitter.

Plans are insured through UnitedHealthcare Insurance Company or one of its affiliated companies, a Medicare Advantage organization with a Medicare contract. Enrollment in the plan depends on the plan’s contract renewal with Medicare.

These events are only for educational purposes.

1 CMS Data, August 2017, and NAIC statutory filings, December 2016.

2 https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf

3 UnitedHealthcare internal data (unique lives only), 2017.

EN
10/01/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DEXCOM INC.

Dexcom Inc: 1 director

Two Directors at Dexcom Inc bought/sold 1,120 shares at between 0.000USD and 68.010USD. The significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...

Research Team ACF
  • Research Team ACF

KDST + NLSP Combined Core Investment Case 29052025

We consider the merged platform Kadimastem (KDST.TA) + NLS Pharmaceutics (NLSP:NasdaqCM). We provide an investment case analysis and a selection of merged metrics prior to any synergies. The merger creates a cross-platform pre-revenue biotech with lead programs including a proprietary stem-differentiation platform capable of delivering scalable therapies for replacing lost or damaged cells; IsletRx could revolutionize insulin production for Type 1 diabetes (T1D) patients; AstroRx® targets neurod...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

OSK OSHKOSH CORP
DXCM DEXCOM INC.
XRAY DENTSPLY SIRONA INC.
WING WINGSTOP INC.
VRTS VIRTUS INVESTMENT PARTNERS INC.
UHS UNIVERSAL HEALTH SERVICES INC. CLASS B
STKS ONE GROUP HOSPITALITY
SNPS SYNOPSYS INC.
SMG SCOTTS MIRACLE-GRO COMPANY CLASS A
SFST SOUTHERN FIRST BANCSHARES
RGNX REGENXBIO INC.
RCKY ROCKY BRANDS
PRGO PERRIGO CO. PLC
MPWR MONOLITHIC POWER SYSTEMS INC.
JRVR JAMES RIVER GROUP HOLDINGS LTD
IRM IRON MOUNTAIN INC.
GPC GENUINE PARTS COMPANY
GD GENERAL DYNAMICS CORPORATION
DLTR DOLLAR TREE INC.
DG DOLLAR GENERAL CORPORATION
CROX CROCS INC.
CAL CALERES INC.
BKE BUCKLE INC.
ASC ARDMORE SHIPPING
AMOT ALLIED MOTION TECHNOLOGIES
ACAD ACADIA PHARMACEUTICALS INC.
SBL SAFE BULKERS INC.
LPG DORIAN LPG
MEG. MEG ENERGY CORP.
MDU MDU RESOURCES GROUP INC
NAT NORDIC AMERICAN TANKERS LIMITED
EVTC EVERTEC INC.
FSLR FIRST SOLAR INC.
IONS IONIS PHARMACEUTICALS INC.
NMIH NMI HOLDINGS INC. CLASS A
AGYS AGILYSYS INC.
SJM J.M. SMUCKER COMPANY
FIZZ NATIONAL BEVERAGE CORP.
NHC NATIONAL HEALTHCARE CORP.
INSW INTERNATIONAL SEAWAYS INC.
FLGT FULGENT GENETICS
DK DELEK US HOLDINGS INC
CELH CELSIUS HOLDINGS INC.
AMD ADVANCED MICRO DEVICES INC.
TTEC TTEC HOLDINGS INC.
AVGO BROADCOM INC.
ST SENSATA TECHNOLOGIES HOLDING PLC
ELAN ELANCO ANIMAL HEALTH INC.
MEC MAYVILLE ENGINEERING
DELL DELL TECHNOLOGIES INC CLASS C
CSTM CONSTELLIUM SE CLASS A
OI O-I GLASS INC
BWMN BOWMAN CONSULTING GROUP LTD
DINO HOLLYFRONTIER CORP
EVEX EVE HOLDING INC
SPXC SPX TECHNOLOGIES INC
WEST WESTROCK COFFEE COMPANY LLC
ADCT ADC THERAPEUTICS SA
SVV SAVERS VALUE VILLAGE INC
GUTS FRACTYL HEALTH INC
AGEN AGENUS INC.
ARDT ARDENT HEALTH PARTNERS INC
PCT PROVIDENT CAP TR II SKIS 8.75%29
MKTW MARKETWISE INC
 PRESS RELEASE

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medi...

EDINBURGH, Scotland & SAN DIEGO--(BUSINESS WIRE)-- (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across Europe and the Middle East." The report surveyed over 2,500 people, made up of individuals with Type 2 diabetes and healthcare professionals, from Germany, Italy, the Netherlands, Saudi Arabia, Spain and the United Kingdom. The findings provide valuable insights into access to care and perceptions of diabetes technology. During the conference, first-ever accuracy a...

Research Team ACF
  • Research Team ACF

ACF Thematic Research Regenerative Medicine Diabetes Treatment & Innov...

Diabetes mellitus, Type 1 (T1D) and Type 2 (T2D, 85-90% of cases), is a USD ~75bn global therapy market. Global economic costs of diabetes may exceed USD1 trn today and USD 450bn in the US, suggesting a pressing global health challenge. Diabetes is a chronic metabolic disorder characterized by high blood sugar levels. In 2024, consensus global estimates suggested there were ~800m adult diabetes sufferers. In 2021, according to the IDF there >530m sufferers globally. For 2027E we modestly forecas...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch